Zenas BioPharma’s Upsized $200 Million Series C Financing Round

Wilson Sonsini Goodrich & Rosati advised SR One, Norwest Venture Partners, and Delos Capital on the transaction.Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced an upsized…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now